[go: up one dir, main page]

AU2001296029A1 - Pharmaceutical preparation of percutaneous absorption type - Google Patents

Pharmaceutical preparation of percutaneous absorption type

Info

Publication number
AU2001296029A1
AU2001296029A1 AU2001296029A AU9602901A AU2001296029A1 AU 2001296029 A1 AU2001296029 A1 AU 2001296029A1 AU 2001296029 A AU2001296029 A AU 2001296029A AU 9602901 A AU9602901 A AU 9602901A AU 2001296029 A1 AU2001296029 A1 AU 2001296029A1
Authority
AU
Australia
Prior art keywords
pharmaceutical preparation
absorption type
percutaneous absorption
percutaneous
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296029A
Other languages
English (en)
Inventor
Kazunosuke Aida
Naruhito Higo
Shuji Sato
Takaaki Terahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of AU2001296029A1 publication Critical patent/AU2001296029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001296029A 2000-11-07 2001-10-30 Pharmaceutical preparation of percutaneous absorption type Abandoned AU2001296029A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000339524 2000-11-07
JP2000-339524 2000-11-07
PCT/JP2001/009496 WO2002038139A1 (en) 2000-11-07 2001-10-30 Pharmaceutical preparation of percutaneous absorption type

Publications (1)

Publication Number Publication Date
AU2001296029A1 true AU2001296029A1 (en) 2002-05-21

Family

ID=18814588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296029A Abandoned AU2001296029A1 (en) 2000-11-07 2001-10-30 Pharmaceutical preparation of percutaneous absorption type

Country Status (6)

Country Link
US (1) US20040028724A1 (ja)
EP (1) EP1340496A4 (ja)
JP (1) JP4057418B2 (ja)
AU (1) AU2001296029A1 (ja)
CA (1) CA2428181A1 (ja)
WO (1) WO2002038139A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
AU2001296029A1 (en) * 2000-11-07 2002-05-21 Hisamitsu Pharmaceutical Co., Inc. Pharmaceutical preparation of percutaneous absorption type
CN1250206C (zh) * 2001-03-07 2006-04-12 久光制药株式会社 贴剂
JP4213432B2 (ja) * 2002-08-28 2009-01-21 久光製薬株式会社 貼付剤
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
US20070073338A1 (en) * 2003-09-04 2007-03-29 Roy Raghunandan Supercutaneous method and device for promoting hemostasis in cannulated patient
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
JPWO2005115355A1 (ja) * 2004-05-28 2008-03-27 久光製薬株式会社 貼付製剤
JPWO2005117886A1 (ja) * 2004-06-01 2008-04-03 久光製薬株式会社 貼付剤
EP1611882B1 (en) * 2004-06-01 2010-04-07 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
JP4986411B2 (ja) * 2004-06-01 2012-07-25 久光製薬株式会社 貼付剤
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080138388A1 (en) * 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
WO2006093139A1 (ja) 2005-02-28 2006-09-08 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収製剤
JP5122445B2 (ja) * 2006-05-08 2013-01-16 帝國製薬株式会社 抗認知症薬物の経皮吸収製剤
EP2255802B1 (en) 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
JP5537412B2 (ja) * 2008-02-27 2014-07-02 久光製薬株式会社 貼付製剤
US20110189261A1 (en) * 2008-03-03 2011-08-04 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5368168B2 (ja) * 2008-06-16 2013-12-18 日東電工株式会社 貼付剤及び貼付製剤
ITMI20081652A1 (it) * 2008-09-16 2010-03-17 Antica Ritrovati Medicinal I S A R M Srl Soc Composizioni transdermiche per immunoterapia specifica iposensibilizzante
CN105419206B (zh) * 2009-07-30 2017-12-15 赢创罗姆有限公司 包含共聚物、二羧酸和脂肪单羧酸的粉末状或粒状组合物
CA2769438C (en) 2009-07-30 2017-01-03 Evonik Roehm Gmbh Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid
KR20120101704A (ko) * 2009-12-16 2012-09-14 고토 다케시 항인지증 약물의 경피흡수제제
JPWO2011074637A1 (ja) 2009-12-16 2013-04-25 後藤 武 抗認知症薬物の経皮吸収製剤
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
JP5631854B2 (ja) * 2010-12-13 2014-11-26 久光製薬株式会社 医薬組成物および貼付剤
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
KR20150059177A (ko) 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
ES2841138T3 (es) 2013-09-11 2021-07-07 Medrx Co Ltd Composición de base novedosa para agente de cinta adhesiva
EP3384910A4 (en) * 2015-12-04 2019-07-31 Nichiban Co., Ltd. TRANSDERMAL STAMP
IL303255A (en) 2015-12-30 2023-07-01 Corium Inc Systems and methods for long term transdermal administration
MX394249B (es) * 2016-07-27 2025-03-24 Corium Int Inc Sistema de suministro transdermico de donepezilo.
ES2968551T3 (es) * 2018-01-31 2024-05-10 Medrx Co Ltd Sistema terapéutico de tizanidina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
DE3581428D1 (de) * 1984-06-13 1991-02-28 Roehm Gmbh Verfahren zum ueberziehen von arzneiformen.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
EP0387751B1 (en) * 1989-03-15 1994-06-08 Nitto Denko Corporation Medicated plasters
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
JP2977254B2 (ja) 1990-09-04 1999-11-15 積水化学工業株式会社 経皮吸収貼付剤
JP3253431B2 (ja) * 1993-09-29 2002-02-04 積水化学工業株式会社 医療用貼付材
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
WO1998013035A1 (fr) * 1996-09-26 1998-04-02 Nitto Denko Corporation Preparations percutanees
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
IT1317736B1 (it) * 2000-01-26 2003-07-15 A C R Applied Coating Res S A Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.
AU2001296029A1 (en) * 2000-11-07 2002-05-21 Hisamitsu Pharmaceutical Co., Inc. Pharmaceutical preparation of percutaneous absorption type

Also Published As

Publication number Publication date
JP4057418B2 (ja) 2008-03-05
EP1340496A1 (en) 2003-09-03
EP1340496A4 (en) 2004-04-14
JPWO2002038139A1 (ja) 2004-03-11
CA2428181A1 (en) 2002-05-16
US20040028724A1 (en) 2004-02-12
WO2002038139A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2001296029A1 (en) Pharmaceutical preparation of percutaneous absorption type
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2002225855A1 (en) Preparation of nanocrystallites
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
DZ3311A1 (fr) Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001248943A1 (en) Pharmaceutical curative compound
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001284763A1 (en) Preparation of risperidone
AU4085201A (en) Pharmaceutical composition
AU3586401A (en) Pharmaceutical composition
AU2001292578A1 (en) Pharmaceutical compounds
AU2001250625A1 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
AU2001278705A1 (en) Pharmaceutical composition
AU2001292001A1 (en) Pharmaceutical oxan preparation
AU2001282541A1 (en) Medicinal compositions
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU2002328602A1 (en) Percutaneous absorption type medicinal preparation